Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Oxford skyline

This new course will provide a thorough grounding and introduction to those planning on becoming a Chief Investigator or those recently appointed to this role. The day will consist of presentations on how to communicate effectively, facilitating the actions required from a CI, guidance on the methods that can be employed, issues that may occur and how to develop and report your trial.

The course is free of charge and will include lunch and refreshments and a comprehensive delegate pack including associated reading.  The presentations will be given by experienced Chief Investigators, Regulatory Experts and senior members of OCTRU and the Centre for Statistics in Medicine.

The course will be held in the Lecture Theatre at the Botnar Research Centre, Oxford.

PLEASE NOTE PLACES ARE LIMITED.  To reserve a place, please email octrutrialshub@ndorms.ox.ac.uk to receive further details. 

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.